title: Did Reduced Alveolar Delivery of Surfactant Contribute to Negative Results in Adults with Acute Respiratory Distress Syndrome?
authors.affiliation: 1 University of Michigan Ann Arbor, Michigan.
authors.forename: James B
authors.initials: JB
authors.lastname: Grotberg
authors.affiliation: 2 Université Paris-Est Créteil, France.|3 École Polytechnique Palaiseau, France.
authors.forename: Marcel
authors.initials: M
authors.lastname: Filoche
authors.affiliation: 4 Virginia Commonwealth University Richmond, Virginia and.
authors.forename: Douglas F
authors.initials: DF
authors.lastname: Willson
authors.affiliation: 1 University of Michigan Ann Arbor, Michigan.
authors.forename: Krishnan
authors.initials: K
authors.lastname: Raghavendran
authors.affiliation: 5 University of Rochester Rochester, New York.
authors.forename: Robert H
authors.initials: RH
authors.lastname: Notter
mesh_terms: D000328:Adult; D006801:Humans; D007231:Infant, Newborn; D011663:Pulmonary Surfactants / Q000627:therapeutic use*; D012128:Respiratory Distress Syndrome / Q000188:drug therapy*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D011663:Pulmonary Surfactants